BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Salient Surgical Technologies Brings the Benefits of TRANSCOLLATION(TM) Technology to the Orthopedic Trauma Market


4/14/2010 11:44:47 AM

PORTSMOUTH, NH--(Marketwire - April 14, 2010) -

As part of its continuing efforts to improve patient outcomes and reduce non-routine discharges for its hospital customers, Salient Surgical Technologies, Inc. today announced the availability of its line of AQUAMANTYS® bipolar sealers for use in orthopedic trauma procedures.

Already in wide use for spinal fusion and orthopedic reconstruction of the hip and knee, the AQUAMANTYS System can help the surgeon achieve hemostasis quickly while avoiding damage to delicate structures. Typical applications include lower limb amputation, pelvic osteotomy, and large debridement procedures; sacral, hip, periprosthetic and femoral fractures and long bone non-union procedures.

The AQUAMANTYS System employs TRANSCOLLATION technology, Salient's proprietary combination of radiofrequency energy and saline that seals specific types of collagen based tissues while maintaining temperatures at or below one-hundred degrees Celsius.

"Our customers tell us that the two things that matter most for good patient outcomes in orthopedic trauma cases are a good reduction and gentle tissue management," said Joseph F. Army, President and Chief Executive Officer of Salient. "The AQUAMANTYS System's ability to deliver gentle, low-temperature hemostasis makes this entry into trauma procedures a natural progression in the expanding adoption of TRANSCOLLATION technology."

About Salient Surgical Technologies
Salient Surgical Technologies, Inc. is a medical technology company that develops and markets advanced energy devices for use in surgical procedures. Salient's proprietary TRANSCOLLATION™ technology allows surgeons to rapidly treat tissue at the surgical site by transforming specific types of collagen based structures to improve patient outcomes. Salient's products are currently used in orthopedic reconstruction, spine and surgical oncology. To date, TRANSCOLLATION™ technology has been used in over 400,000 surgical procedures.


Contact:
Rick Altieri
(603) 742-1515
Email Contact



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES